Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 66Colonic Neoplasms 31Rectal Neoplasms 30Pancreatic Neoplasms 18Stomach Neoplasms 16Carcinoma, Hepatocellular 14Neoplasm Metastasis 13Esophageal Neoplasms 6Leukemia 5Neoplasms 4Lymphoma 4Liver Neoplasms 3Cholangiocarcinoma 3Carcinoma 3Adenocarcinoma Of Esophagus 3Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Leukemia, Biphenotypic, Acute 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Biliary Tract Neoplasms 2Bile Duct Neoplasms 2mCRC 1Unresectable Sinonasal Tumors 1Thymoma 1Small Cell Lung Carcinoma 1

Interventions

Oxaliplatin 5Irinotecan 5Panitumumab 4Capecitabine 4Bevacizumab 4Cetuximab 3Leucovorin 2Fluorouracil 2trifluridine tipiracil drug combination 1spartalizumab 1regorafenib 1raltitrexed 1pembrolizumab 1camrelizumab 1aflibercept 1XELOX 1Radiotherapy 1Radiosurgery 1Lycopene 1Loperamide 1Ethiodized Oil 1Drug Therapy 1Cytoreduction Surgical Procedures 1Antineoplastic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Colorectal Cancer Metastatic × Leucovorin × Clear all
NCT04169347 2023-07-27

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Criterium, Inc.

Phase 2 Unknown
27 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03751176 2021-06-30

BEYOND

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡